BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 17426850)

  • 1. Rheumatoid course of humoral (vascular) rejection after heart allotransplantation.
    Beletskaya LV; Kupriyanova AG; Kormer AY; Mironkov BL; Kazakov EN; Shumakov VI
    Bull Exp Biol Med; 2006 Sep; 142(3):363-6. PubMed ID: 17426850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of humoral rejection in human cardiac allografts by assessing the capillary deposition of complement fragment C4d in endomyocardial biopsies.
    Behr TM; Feucht HE; Richter K; Reiter C; Spes CH; Pongratz D; Uberfuhr P; Meiser B; Theisen K; Angermann CE
    J Heart Lung Transplant; 1999 Sep; 18(9):904-12. PubMed ID: 10528753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serial monitoring of humoral antibody-mediated rejection of cardiac allografts by C4d staining of interstitial capillaries.
    Suggs J; Goodin J; Cruse JM; Lewis RE; Allen B; Bigler S; Moore C; Thompson R; McIntire H
    Exp Mol Pathol; 2009 Feb; 86(1):41-5. PubMed ID: 19111538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spectrum of humoral rejection after pediatric heart transplantation.
    Zales VR; Crawford S; Backer CL; Lynch P; Benson DW; Mavroudis C
    J Heart Lung Transplant; 1993; 12(4):563-71; discussion 572. PubMed ID: 8369319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Humoral immunopathologic changes in the myocardium after clinical allotransplantation of the heart].
    Beletskaia LV; Baranova FS; Khalimova ZA; Kurenkova LG; Kazakov EN; Kormer AI; Chestukhin VV; Za'idenov Va; Boikina TV; Selezneva EA
    Arkh Patol; 1995; 57(6):3-7. PubMed ID: 8742178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C4d-the witness of humoral rejection.
    de Gouveia RH; Vitorino E; Ramos S; Rebocho MJ; Queirós E Melo J; Martins AP; Moura ML
    Transplant Proc; 2009 Apr; 41(3):866-7. PubMed ID: 19376374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Asymptomatic antibody-mediated rejection after heart transplantation predicts poor outcomes.
    Wu GW; Kobashigawa JA; Fishbein MC; Patel JK; Kittleson MM; Reed EF; Kiyosaki KK; Ardehali A
    J Heart Lung Transplant; 2009 May; 28(5):417-22. PubMed ID: 19416767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody-mediated rejection in human cardiac allografts: evaluation of immunoglobulins and complement activation products C4d and C3d as markers.
    Rodriguez ER; Skojec DV; Tan CD; Zachary AA; Kasper EK; Conte JV; Baldwin WM
    Am J Transplant; 2005 Nov; 5(11):2778-85. PubMed ID: 16212640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C4D immunostaining in surveillance endomyocardial biopsies from well-functioning heart allografts.
    Arias LF; Fernández R; Fernández D; Jaramillo JC; Gil M; López García-Asenjo JA
    Transplant Proc; 2010 Jun; 42(5):1793-6. PubMed ID: 20620525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for antibody and immune-complex deposition in heart transplantation: a report of three cases.
    Shumakov VI; Beletskaya LV; Baranova FS; Mogilevsky GM; Chestukhin VV; Kormer AYa ; Kazakov EN; Khubutia AS; Kurenkova LG; Khalimova ZA
    J Heart Lung Transplant; 1992; 11(6):1209-12. PubMed ID: 1457448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunostaining of cardiac biopsy specimens in the diagnosis of acute vascular (humoral) rejection: a control study.
    Loy TS; Bulatao IS; Darkow GV; Demmy TL; Reddy HK; Curtis J; Bickel JT
    J Heart Lung Transplant; 1993; 12(5):736-40. PubMed ID: 7694654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reclassification of C4d-Positive Endomyocardial Biopsy (EMB) According to New International Society for Heart and Lung Transplantation (ISHLT) 2013 Categories for Reporting Pathologic Antibody-Mediated Rejection (pAMR): Preliminary Data from a Polish Single-Center Study.
    Szymańska S; Grajkowska W; Sobieszczańska-Małek M; Zieliński T; Pronicki M
    Ann Transplant; 2015 Jun; 20():351-6. PubMed ID: 26101425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Humoral heart rejection (severe allograft dysfunction with no signs of cellular rejection or ischemia): incidence, management, and the value of C4d for diagnosis.
    Crespo-Leiro MG; Veiga-Barreiro A; Doménech N; Paniagua MJ; Piñón P; González-Cuesta M; Vázquez-Martul E; Ramirez C; Cuenca JJ; Castro-Beiras A
    Am J Transplant; 2005 Oct; 5(10):2560-4. PubMed ID: 16162208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utility of routine immunofluorescence staining for C4d in cardiac transplant recipients.
    Gupta S; Mitchell JD; Lavingia B; Ewing GE; Feliciano MN; Kaiser PA; Ring WS; Stastny P; Patel PC; Markham DW; Mammen PP; Dimaio JM; Drazner MH
    J Heart Lung Transplant; 2009 Aug; 28(8):776-80. PubMed ID: 19632572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of Circulating Complement-Fixing Donor-Specific Antibodies Identified by the C1q Assay and Presence of C4d in Endomyocardial Biopsy Specimens.
    Frank R; Lal P; Kearns J; Molina MR; Wald JW; Goldberg LR; Kamoun M
    Am J Clin Pathol; 2016 Jan; 145(1):62-8. PubMed ID: 26712872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of c4d immunostaining utilizing paraffin-embedded tissue of nonpresensitized pediatric heart transplant patients.
    Galambos C; Feingold B; Webber SA
    Pediatr Dev Pathol; 2008; 11(3):181-4. PubMed ID: 17990923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. C4d deposition and clearance in cardiac transplants correlates with alloantibody levels and rejection in rats.
    Minami K; Murata K; Lee CY; Fox-Talbot K; Wasowska BA; Pescovitz MD; Baldwin WM
    Am J Transplant; 2006 May; 6(5 Pt 1):923-32. PubMed ID: 16611328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute humoral rejection and C4d immunostaining in ABO blood type-incompatible liver transplantation.
    Haga H; Egawa H; Fujimoto Y; Ueda M; Miyagawa-Hayashino A; Sakurai T; Okuno T; Koyanagi I; Takada Y; Manabe T
    Liver Transpl; 2006 Mar; 12(3):457-64. PubMed ID: 16498648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complement deposition in early cardiac transplant biopsies is associated with ischemic injury and subsequent rejection episodes.
    Baldwin WM; Samaniego-Picota M; Kasper EK; Clark AM; Czader M; Rohde C; Zachary AA; Sanfilippo F; Hruban RH
    Transplantation; 1999 Sep; 68(6):894-900. PubMed ID: 10515392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antithymocyte globulin is associated with complement deposition in cardiac transplant biopsies.
    Baldwin WM; Armstrong LP; Samaniego-Picota M; Rahimi S; Zachary AA; Kasper EK; Conte JV; Hruban RH; Rodriguez ER
    Hum Immunol; 2004 Nov; 65(11):1273-80. PubMed ID: 15556677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.